Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.755 USD | -5.65% | -17.68% | +27.00% |
Mar. 21 | Fate Therapeutics, Inc. announced that it has received $19.996366 million in funding from Redmile Group, LLC | CI |
Mar. 19 | Fate Therapeutics Prices $100 Million Offering, Private Placement | MT |
- Stock Market
- Equities
- FATE Stock
- News Fate Therapeutics, Inc.